Results 3,021-3,040 of 3,998 for speaker:Michael Harty

Joint Oireachtas Committee on Health: Quarterly Update On Health Issues: Discussion (18 Oct 2017)

Michael Harty: Sorry, but I will ask one question before the Deputy contributes. In terms of workforce planning, does the Department have a vision of how it will approach recruiting? We all know that we need to recruit. Mr. Breslin referred to a satisfactory working arrangement. It is not all about money, but about career satisfaction and progression as well. This issue has a knock-on effect on our...

Joint Oireachtas Committee on Health: Quarterly Update On Health Issues: Discussion (18 Oct 2017)

Michael Harty: Did Mr. O'Brien wish to comment on that matter?

Joint Oireachtas Committee on Health: Quarterly Update On Health Issues: Discussion (18 Oct 2017)

Michael Harty: Other members are waiting to contribute.

Joint Oireachtas Committee on Health: Quarterly Update On Health Issues: Discussion (18 Oct 2017)

Michael Harty: I acknowledge the arrival of the Minister of State, Deputy Jim Daly. The next speaker will be Senator John Dolan followed by Deputy Kate O'Connell.

Joint Oireachtas Committee on Health: Quarterly Update On Health Issues: Discussion (18 Oct 2017)

Michael Harty: I thank the Senator. Perhaps the Minister might bank the questions, as I will now bring in Deputies Louise O'Reilly and Kate O'Connell. As they are sitting beside each other, they can keep an eye on each other in order that they do not drag on too long.

Joint Oireachtas Committee on Health: Quarterly Update On Health Issues: Discussion (18 Oct 2017)

Michael Harty: I thank Deputy O'Connell. We have been here for over two hours. If the witnesses want to take a five minute break we are happy to accommodate that. Are they happy to continue? The witnesses have a large number of questions. Senator Dolan's questions were first. Who wants to take them?

Joint Oireachtas Committee on Health: Quarterly Update On Health Issues: Discussion (18 Oct 2017)

Michael Harty: I thank Mr. O'Brien. Mr. Breslin was going to address some other issues.

Joint Oireachtas Committee on Health: Quarterly Update On Health Issues: Discussion (18 Oct 2017)

Michael Harty: Perhaps the Minister of State, Deputy Finian McGrath, will respond on that.

Joint Oireachtas Committee on Health: Quarterly Update On Health Issues: Discussion (18 Oct 2017)

Michael Harty: You were not present when Senator Dolan asked the question so perhaps Senator Dolan will ask it again.

Joint Oireachtas Committee on Health: Quarterly Update On Health Issues: Discussion (18 Oct 2017)

Michael Harty: I have two questions that either Mr. Breslin or Mr. O'Brien might address. One concerns the funding mechanisms for primary care centres as I understand that there are several different mechanisms to bring these centres into being. Could the witnesses address how these mechanisms function and which is the most successful or commonly used to bring a primary care centre to completion? My...

Joint Oireachtas Committee on Health: Quarterly Update On Health Issues: Discussion (18 Oct 2017)

Michael Harty: Does Mr. O'Brien wish to add any comment to that?

Joint Oireachtas Committee on Health: Quarterly Update On Health Issues: Discussion (18 Oct 2017)

Michael Harty: I thank the Minister, Deputy Harris, for coming back from the Cabinet meeting. He was not indispensable in that we kept going but I thank him for coming back. He probably picked up on the question I was asking on primary care centres. To be parochial, over several years there have been several runs at trying to develop primary care centres in Ennis, and each has failed to date. Perhaps...

Joint Oireachtas Committee on Health: Quarterly Update On Health Issues: Discussion (18 Oct 2017)

Michael Harty: In our Estimates discussion a number of weeks ago, we noted the take from private health insurance coming into the public system was declining. Therefore, the public system is dependent on fairly volatile private insurance income to support public services. That is not a model that can continue.

Joint Oireachtas Committee on Health: Quarterly Update On Health Issues: Discussion (18 Oct 2017)

Michael Harty: I thank the Minister for coming back for such a short part of the meeting. On behalf of the committee, I thank Mr. Jim Breslin, the Minister, Deputy Harris, the two Ministers of State, Deputy Jim Daly and Deputy Finian McGrath, and Mr. O'Brien, Mr. Woods and Ms Mannion for attending.

Local Authority Boundaries Review: Motion [Private Members] (17 Oct 2017)

Michael Harty: I also speak in favour of this motion. This is an issue which is not confined to Cork. It also relates to boundary changes in Waterford and Kilkenny regarding Ferrybank, Roscommon and Westmeath regarding Monksland, and also in Clare and Limerick. In the last case it proved a very contentious issue in 2011 when Limerick city proposed to annex a portion of south east Clare into Limerick...

Written Answers — Department of Health: Medicinal Products Reimbursement (17 Oct 2017)

Michael Harty: 277. To ask the Minister for Health if he will direct the HSE to review its decision and the processes used in arriving at the decision not to approve for reimbursement of the drug Translarna for treatment of Duchenne muscular dystrophy in view of the fact that many other countries have given such approval; and if he will make a statement on the matter. [43401/17]

Written Answers — Department of Health: Medicinal Products Reimbursement (17 Oct 2017)

Michael Harty: 404. To ask the Minister for Health his plans to intervene in the unprecedented High Court appeal brought by a company (details supplied) against the HSE decision not to reimburse for Translarna for the treatment of Duchenne muscular dystrophy in two persons in view of the fact that this legal process will be more costly than providing the drug and may result in these two persons missing...

Written Answers — Department of Health: Medicinal Products Reimbursement (17 Oct 2017)

Michael Harty: 405. To ask the Minister for Health if his Department or the HSE will work towards an interim arrangement to treat the persons with Duchenne muscular dystrophy who require Translarna here should a lengthy legal process unfold; and if he will make a statement on the matter. [44064/17]

Written Answers — Department of Health: Medicinal Products Reimbursement (17 Oct 2017)

Michael Harty: 406. To ask the Minister for Health the reason the HSE’s decision not to reimburse for Translarna was at odds with 22 other European countries; and if he will make a statement on the matter. [44065/17]

Written Answers — Department of Health: Medicinal Products Reimbursement (17 Oct 2017)

Michael Harty: 407. To ask the Minister for Health if he is satisfied that appropriate negotiations have taken place between the HSE and a company (details supplied) ahead of the company resorting to legal action; and if he will make a statement on the matter. [44066/17]